The signature was distributed equally between the breast cancer biological subtypes (Additional file 3; Supplementary Fig. 2) and was not associated with ER, PR or HER2 (Additional file 3; Supplementary Fig. 3) or tumor size, nodal status or grade (Additional file 3; Supplementary Fig. 4). This evidence concerns the gene ERBB2 and breast cancer.